Eli Lilly is acquiring Centessa Pharmaceuticals in a $6.3 billion deal that gives the company a contender in an emerging class of narcolepsy medicines that also have potential applications in
Jimini Health has raised $17 million in seed funding to help behavioral health organizations safely deploy AI at scale, the company announced on Tuesday. The New York-based company is building
AI early-stage companies are developing applications to help clinicians and staff with a range of work activities, from automated administrative work that reduces documentation time and frees up clinician hours,
Between 5 and 10 million people could lose Medicaid coverage in 2028 due to changes from the One Big Beautiful Bill Act, depending on the steps states take to mitigate
Deciding which AI tools to adopt isn’t about hype — it’s about evidence and real-world impact, according to Rebecca Mishuris, chief health information officer and vice president of digital at
Kailera Therapeutics isn’t the only company developing an obesity drug that hits multiple targets for weight loss, but the clinical-stage biotech believes its lead drug candidate can beat other medicines
A Rocket Pharmaceuticals gene therapy has landed a long-awaited FDA approval, bringing a new treatment option to patients with a certain inherited immunodeficiency so severe that many babies do not
Everlywell, an at-home lab testing company, is partnering with AI-powered gut microbiome company Jona to bring a gut microbiome test to consumers nationwide. Everlywell is a direct-to-consumer company selling tests
Health systems should use data to identify problems before buying AI tools, according to Arcadia CEO Michael Meucci. The market is flooded with vendors pitching AI solutions — but instead
For years, robotic bronchoscopy was confined mainly to elite academic centers and referral hospitals that possessed the budgets, staffing, and infrastructure required to support early-generation systems. That era is ending.
